Emergency pharmaceutical - galafold (MIGALASTAT) 123MG
Ended Awarded
- Contract number
- 36C26124N0699
- Awardee
-
Amicus Therapeutics US, LLC UEI KLJFGENKMD89 Part of Amicus Therapeutics, Inc.
- Awarding agency
-
Veterans Integrated Service Network 21
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $21,089
Award facts
- Contract value 100% obligated
- $21,089.47 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Philadelphia, PA 19104, USA
Award details come from SAM.gov/FPDS.
About this award
This is a delivery order awarded by the Department of Veterans Affairs (VA) to Amicus Therapeutics US, LLC, a subsidiary of Amicus Therapeutics, Inc., under the General Services Administration's (GSA) Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule contract. The delivery order is for the emergency pharmaceutical Galafold (migalastat) 123mg, an FDA-approved enzyme replacement therapy used to treat Fabry disease, a rare genetic disorder. The delivery order has a ceiling value of $21,089.47 and a period of performance through June 21, 2024. No set-aside designation was applied. This delivery order is part of Amicus Therapeutics US, LLC's ongoing work supplying Galafold to VA facilities and service networks nationwide under the GSA FSS contract to support the VA's mission of providing healthcare to veterans.
Quick answers
Who was awarded contract 36C26124N0699?
36C26124N0699 was awarded to Amicus Therapeutics US, LLC by Veterans Integrated Service Network 21 (Veterans Health Administration) on June 6, 2024.
How much is contract 36C26124N0699 worth?
The government has obligated $21,089 on 36C26124N0699.
Is contract 36C26124N0699 an order under another contract?
Yes. 36C26124N0699 is a delivery order under 36F79719D0108, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26124N0699 competed?
The extent of competition for 36C26124N0699 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award